{"id":"NCT01474772","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","briefTitle":"Efficacy and Safety Study of Pregabalin in the Treatment of Pain on Walking in Patients With Diabetic Peripheral Neuropathy (DPN)","officialTitle":"A Phase 3b Multicenter, Double-blind, Randomized, Placebo-controlled Cross-over Efficacy And Safety Study Of Pregabalin In The Treatment Of Patients With Painful Diabetic Peripheral Neuropathy And Pain On Walking","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-10","primaryCompletion":"2013-07","completion":"2013-07","firstPosted":"2011-11-18","resultsPosted":"2014-11-18","lastUpdate":"2021-01-28"},"enrollment":217,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Diabetic Peripheral Neuropathy"],"interventions":[{"type":"DRUG","name":"Pregabalin","otherNames":["Lyrica"]},{"type":"OTHER","name":"placebo","otherNames":[]}],"arms":[{"label":"Pregabain","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The intent of this study is to treat subjects with painful Diabetic Peripheral Neuropathy (DPN) who also have pain on walking and to determine whether or not pregabalin demonstrates improvement relative to placebo on the following: reducing DPN pain, reducing pain on walking, and providing other benefits associated with daily activities and quality of life.","primaryOutcome":{"measure":"Average Diabetic Peripheral Neuropathy (DPN) Pain Based on a Numeric Rating Scale (NRS) Over the Last 7 Days of Each Treatment Period (Week 6 of Each Treatment Period)","timeFrame":"End of Period (includes both Visits 6 and 11)","effectByArm":[{"arm":"Pregabalin","deltaMin":4.73,"sd":0.14},{"arm":"Placebo","deltaMin":4.96,"sd":0.14}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0659"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":2},"locations":{"siteCount":45,"countries":["United States","Czechia","South Africa","Sweden"]},"refs":{"pmids":["25565583"],"seeAlso":["https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=A0081269&StudyName=Efficacy%20and%20Safety%20Study%20of%20Pregabalin%20in%20the%20Treatment%20of%20Pain%20on%20Walking%20in%20Patients%20with%20Diabetic%20Peripheral%20Neuropathy%20%28DPN%29"]},"adverseEventsSummary":{"seriousAny":{"events":9,"n":198},"commonTop":["Dizziness","Somnolence","Fatigue","Upper respiratory tract infection","Headache"]}}